因子Xa抑制剂与直接凝血酶抑制剂对比低分子量肝素在全髋或全膝关节置换术后血栓预防中的系统评价与Meta分析
该系统评价与Meta分析检索至2017年6月30日的随机对照研究,纳入32项,比较全膝或全髋关节置换术后低分子量肝素与其他抗凝药的静脉血栓栓塞预防效果。在全膝和全髋患者中,因子Xa抑制剂的静脉血栓栓塞发生率低于低分子量肝素;在全髋患者中直接凝血酶抑制剂的静脉血栓栓塞发生率低于低分子量肝素。三类药物的肺栓塞和大出血发生率相似。
要点
- 在全膝和全髋关节置换患者中,因子Xa抑制剂的静脉血栓栓塞发生率低于低分子量肝素。
- 在全髋患者中,直接凝血酶抑制剂的静脉血栓栓塞发生率低于低分子量肝素,深静脉血栓发生率相似。
- 在全膝患者中,低分子量肝素与直接凝血酶抑制剂的静脉血栓栓塞和深静脉血栓发生率相似。
核心结论
- 在全膝和全髋关节置换患者中,低分子量肝素的静脉血栓栓塞发生率高于因子Xa抑制剂。
- 直接凝血酶抑制剂在全髋患者中静脉血栓栓塞发生率较低,但其在全膝和全髋患者中预防深静脉血栓和肺栓塞的效果与低分子量肝素相似。
研究设计与样本
- 系统评价与Meta分析,检索MEDLINE、Cochrane、EMBASE和Google Scholar数据库至2017年6月30日,纳入32项随机对照研究。
主要发现
- 低分子量肝素对静脉血栓栓塞的预防优于安慰剂。
- 在全膝和全髋患者中,因子Xa抑制剂的静脉血栓栓塞发生率低于低分子量肝素。
- 在全髋患者中,因子Xa抑制剂的深静脉血栓发生率低于低分子量肝素。
- 在全膝患者中,低分子量肝素与直接凝血酶抑制剂的静脉血栓栓塞和深静脉血栓发生率相似。
- 在全髋患者中,直接凝血酶抑制剂的静脉血栓栓塞发生率低于低分子量肝素,而深静脉血栓发生率相似。
关键数值与推荐
- 在全膝和全髋患者中,三类药物的肺栓塞发生率相似,大出血发生率也相似。
- 三类药物的非大出血和小出血发生率也相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study is to perform a meta-analysis to compare outcomes of venous thromboembolism (VTE) prophylaxis with low-molecular-weight heparin (LMWH) vs other anticoagulants in patients who received total knee (TKA) or total hip arthroplasty (THA). METHODS: MEDLINE, Cochrane, EMBASE, and Google Scholar databases were searched until June 30, 2017 for eligible randomized controlled studies. RESULTS: Thirty-two randomized controlled studies were included. LMWH provided better protection against VTE than placebo. In both TKA and THA patients, the rates of VTE were lower with factor Xa inhibitors than LMWH. In THA patients, the rate of deep vein thrombosis (DVT) was lower with factor Xa inhibitors than LMWH. In TKA patients, the rates of VTE and DVT were similar between LMWH and direct thrombin inhibitors. In THA patients, the rate of VTE was lower with direct thrombin inhibitors than with LMWH, while the DVT rates were similar. The pulmonary embolism rates were similar between all 3 classes of drugs in TKA and THR patients, as were the major bleeding rates. Nonmajor and minor bleeding rates were also similar between the 3 drug classes. CONCLUSION: LMWH is associated with a higher rate of VTE than factor Xa inhibitors in TKA and THA patients. Direct thrombin inhibitors are associated with a lower rate of VTE in THA patients, but their effectiveness with respect to DVT and pulmonary embolism prophylaxis is similar to that of LMWH in TKA and THA patients.
引用
- Sun G, Wu J, Wang Q, et al. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplasty. 2018. PMID: 30685261. doi:10.1016/j.arth.2018.11.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。